Magdalena Fay, MD MS

Independent blinded validation of an AI-based digital histology classifier for #ProstateCancer recurrence and metastasis risk prediction. Presented by @MagdaFayMD. #ASCO24 written coverage by @zklaassen_md > bit.ly/3Vr6POe @ASCO

Independent blinded validation of an AI-based digital histology classifier (PATHOMIQ_PRAD score) for BCR and mets risk prediction #ASCO24 @MagdaFayMD @urotoday @CleClinicUro ⚡️n=263 RP (mF/U 50 mo) -> 65 BCR -> 14 distant mets ⚡️PATHOMIQ_PRAD score ⬆️ vs ⬇️: assoc with BCRFS (p<0.0001) and MFS (p<0.0001) ⚡️Decipher GC score ⬆️ vs ⬇️: assoc with BCRFS (p=0.0009) and MFS (p=0.0095)

AI digital histology for prostate cancer recurrence and metastasis prediction. 🥇@ASCO @ConquerCancerFd🥇 Outstanding work by recent MD grad @MagdaFayMD @CleClinicLCM @mghmedres and @RossLiao @zaeemlone_ @CleClinicUroRes @shilpaonc @cjweight @EricKleinMD @JaneNguyen44 #ASCO24

Grateful to my mentors & friends @CleClinicLCM who supported me on this journey to M.D.